{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:37:35Z","timestamp":1791293855436,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Chem."],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glucagon is used to treat severe hypoglycaemia in patients with diabetes, and PTH(1\u201334), an N-terminal fragment of parathyroid hormone, is used to treat osteoporosis. Each peptide activates a cognate G-protein-coupled receptor (GPCR). High-resolution structures of peptide\u2013receptor complexes show that glucagon and PTH(1\u201334) are fully \u03b1-helical in the bound state. Here we describe a design strategy that destabilizes the helical conformation of glucagon or PTH(1\u201334) but nevertheless delivers potent agonists of each receptor. Replacement of multiple\n                    <jats:sc>l<\/jats:sc>\n                    -\u03b1-amino-acid residues with\n                    <jats:sc>d<\/jats:sc>\n                    -\u03b1-amino-acid residues, at selected positions, generates heterochiral analogues of both glucagon and PTH(1\u201334) that approach the all-\n                    <jats:sc>l<\/jats:sc>\n                    peptide in receptor activation potency (cAMP production). The heterochiral agonists are biased away from \u03b2-arrestin recruitment relative to the all-\n                    <jats:sc>l<\/jats:sc>\n                    peptide. The glucagon analogues are also biased away from receptor internalization relative to glucagon itself. These unanticipated findings for two dissimilar class B1 GPCRs raise the prospect that heterochiral design will be impactful for other members of this receptor family, which includes multiple therapeutic targets.\n                  <\/jats:p>","DOI":"10.1038\/s41557-026-02182-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:03:33Z","timestamp":1781600613000},"page":"1639-1649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potent and biased agonists of class B1 GPCRs from a heterochiral design strategy"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-0218","authenticated-orcid":false,"given":"Ruslan","family":"Gibadullin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7554-676X","authenticated-orcid":false,"given":"Lauren My-Linh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rylie K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel J.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Mannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-6422","authenticated-orcid":false,"given":"Tae Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-2986","authenticated-orcid":false,"given":"Giuseppe","family":"Deganutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-0058","authenticated-orcid":false,"given":"Samuel H.","family":"Gellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2182_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41573-020-0062-z","volume":"19","author":"AP Davenport","year":"2020","unstructured":"Davenport, A. P., Scully, C. C. G., de Graaf, C., Brown, A. J. H. & Maguire, J. J. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat. Rev. Drug Discov. 19, 389\u2013413 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2182_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/endrev\/bnac033","volume":"44","author":"BP Cary","year":"2023","unstructured":"Cary, B. P. et al. New insights into the structure and function of Class B1 GPCRs. Endocr. Rev. 44, 492\u2013517 (2023).","journal-title":"Endocr. Rev."},{"key":"2182_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00435-w","volume":"6","author":"D Yang","year":"2021","unstructured":"Yang, D. et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct. Target. Ther. 6, 7 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2182_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nbt0797-673","volume":"15","author":"DJ Drucker","year":"1997","unstructured":"Drucker, D. J. et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat. Biotechnol. 15, 673\u2013677 (1997).","journal-title":"Nat. Biotechnol."},{"key":"2182_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1021\/acsptsci.9b00016","volume":"2","author":"DJ Drucker","year":"2019","unstructured":"Drucker, D. J. The discovery of GLP-2 and development of teduglutide for short bowel syndrome. ACS Pharmacol. Transl. Sci. 2, 134\u2013142 (2019).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2182_CR6","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","volume":"58","author":"J Lau","year":"2015","unstructured":"Lau, J. et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J. Med. Chem. 58, 7370\u20137380 (2015).","journal-title":"J. Med. Chem."},{"key":"2182_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08793-y","volume":"10","author":"J Fremaux","year":"2019","unstructured":"Fremaux, J. et al. Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo. Nat. Commun. 10, 924 (2019).","journal-title":"Nat. Commun."},{"key":"2182_CR8","doi-asserted-by":"publisher","first-page":"14486","DOI":"10.1021\/jacs.9b04179","volume":"141","author":"S Liu","year":"2019","unstructured":"Liu, S. et al. Use of backbone modification to enlarge the spatiotemporal diversity of parathyroid hormone receptor-1 signaling via biased agonism. J. Am. Chem. Soc. 141, 14486\u201314490 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41589-021-00945-w","volume":"18","author":"BP Cary","year":"2022","unstructured":"Cary, B. P. et al. Structural and functional diversity among agonist-bound states of the GLP-1 receptor. Nat. Chem. Biol. 18, 256\u2013263 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2182_CR10","doi-asserted-by":"publisher","first-page":"14970","DOI":"10.1021\/jacs.6b08323","volume":"138","author":"MV Hager","year":"2016","unstructured":"Hager, M. V., Johnson, L. M., Wootten, D., Sexton, P. M. & Gellman, S. H. \u03b2-arrestin-biased agonists of the GLP-1 receptor from \u03b2-amino acid residue incorporation into GLP-1 analogues. J. Am. Chem. Soc. 138, 14970\u201314979 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt.2920","volume":"32","author":"RW Cheloha","year":"2014","unstructured":"Cheloha, R. W., Maeda, A., Dean, T., Gardella, T. J. & Gellman, S. H. Backbone modification of a polypeptide drug alters duration of action in vivo. Nat. Biotechnol. 32, 653\u2013655 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2182_CR12","doi-asserted-by":"publisher","first-page":"eaaz4988","DOI":"10.1126\/sciadv.aaz4988","volume":"6","author":"P Sang","year":"2020","unstructured":"Sang, P. et al. The activity of sulfono-\u03b3-AApeptide helical foldamers that mimic GLP-1. Sci. Adv. 6, eaaz4988 (2020).","journal-title":"Sci. Adv."},{"key":"2182_CR13","doi-asserted-by":"publisher","first-page":"13893","DOI":"10.1021\/acs.jmedchem.1c01289","volume":"64","author":"P Sang","year":"2021","unstructured":"Sang, P. et al. \u03b1\/Sulfono-\u03b3-AApeptide hybrid analogues of glucagon with enhanced stability and prolonged in vivo activity. J. Med. Chem. 64, 13893\u201313901 (2021).","journal-title":"J. Med. Chem."},{"key":"2182_CR14","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.1039\/C9SC02079A","volume":"10","author":"J Fremaux","year":"2019","unstructured":"Fremaux, J. et al. Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking. Chem. Sci. 10, 9872\u20139879 (2019).","journal-title":"Chem. Sci."},{"key":"2182_CR15","doi-asserted-by":"publisher","first-page":"20539","DOI":"10.1021\/jacs.3c06703","volume":"145","author":"R Gibadullin","year":"2023","unstructured":"Gibadullin, R., Kim, T. W., Tran, L. M. L. & Gellman, S. H. Hormone analogues with unique signaling profiles from replacement of \u03b1-residue triads with \u03b2\/\u03b3 diads. J. Am. Chem. Soc. 145, 20539\u201320550 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR16","doi-asserted-by":"publisher","first-page":"16688","DOI":"10.1021\/jacs.7b08417","volume":"139","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. Thioamide substitution selectively modulates proteolysis and receptor activity of therapeutic peptide hormones. J. Am. Chem. Soc. 139, 16688\u201316695 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature25153","volume":"553","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Structure of the glucagon receptor in complex with a glucagon analogue. Nature 553, 106\u2013110 (2018).","journal-title":"Nature"},{"key":"2182_CR18","doi-asserted-by":"publisher","first-page":"9313","DOI":"10.1074\/jbc.RA120.013793","volume":"295","author":"R Chang","year":"2020","unstructured":"Chang, R. et al. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide. J. Biol. Chem. 295, 9313\u20139325 (2020).","journal-title":"J. Biol. Chem."},{"key":"2182_CR19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aaz5346","volume":"367","author":"A Qiao","year":"2020","unstructured":"Qiao, A. et al. Structural basis of Gs and Gi recognition by the human glucagon receptor. Science 367, 1346\u20131352 (2020).","journal-title":"Science"},{"key":"2182_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature25773","volume":"555","author":"YL Liang","year":"2018","unstructured":"Liang, Y. L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor\u2013Gs complex. Nature 555, 121\u2013125 (2018).","journal-title":"Nature"},{"key":"2182_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/s41422-020-00442-0","volume":"30","author":"W Sun","year":"2020","unstructured":"Sun, W. et al. A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor. Cell Res. 30, 1098\u20131108 (2020).","journal-title":"Cell Res."},{"key":"2182_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17791-4","volume":"11","author":"M Dong","year":"2020","unstructured":"Dong, M. et al. Structure and dynamics of the active Gs-coupled human secretin receptor. Nat. Commun. 11, 4137 (2020).","journal-title":"Nat. Commun."},{"key":"2182_CR23","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.str.2023.04.002","volume":"31","author":"BP Cary","year":"2023","unstructured":"Cary, B. P. et al. Molecular insights into peptide agonist engagement with the PTH receptor. Structure 31, 668\u2013676.e5 (2023).","journal-title":"Structure"},{"key":"2182_CR24","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1021\/ja9940524","volume":"122","author":"E Krause","year":"2000","unstructured":"Krause, E., Bienert, M., Schmieder, P. & Wenschuh, H. The helix-destabilizing propensity scale of d-amino acids: the influence of side chain steric effects. J. Am. Chem. Soc. 122, 4865\u20134870 (2000).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1397-002x.2001.10994.x","volume":"59","author":"Y Chen","year":"2002","unstructured":"Chen, Y., Mant, C. T. & Hodges, R. S. Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic \u03b1-helix. J. Peptide Res. 59, 18\u201333 (2002).","journal-title":"J. Peptide Res."},{"key":"2182_CR26","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1021\/ja047119i","volume":"126","author":"B Anil","year":"2004","unstructured":"Anil, B., Song, B., Tang, Y. & Raleigh, D. P. Exploiting the right side of the Ramachandran plot: substitution of glycines by D-alanine can significantly increase protein stability. J. Am. Chem. Soc. 126, 13194\u201313195 (2004).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR27","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1021\/acs.jmedchem.5b01909","volume":"59","author":"K Wi\u015bniewski","year":"2016","unstructured":"Wi\u015bniewski, K. et al. Synthesis and pharmacological characterization of novel glucagon-like peptide-2 (GLP-2) analogues with low systemic clearance. J. Med. Chem. 59, 3129\u20133139 (2016).","journal-title":"J. Med. Chem."},{"key":"2182_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-018-0100-5","volume":"2","author":"PA Mroz","year":"2019","unstructured":"Mroz, P. A., Perez-Tilve, D., Mayer, J. P. & DiMarchi, R. D. Stereochemical inversion as a route to improved biophysical properties of therapeutic peptides exemplified by glucagon. Commun. Chem. 2, 2 (2019).","journal-title":"Commun. Chem."},{"key":"2182_CR29","unstructured":"G\u00f6ke, R., Hareter, A., Vahl, T., Bode, H.-P. & Hoffmann, E. in The Insulinotropic Gut Hormone Glucagon-Like Peptide-1 Vol. 13 (eds Feymann, H. C. & G\u00f6ke, R.) 85\u2013104 (Karger, 1997)."},{"key":"2182_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/jm00369a014","volume":"27","author":"J Sueiras-Diaz","year":"1984","unstructured":"Sueiras-Diaz, J., Lance, V. A., Murphy, W. A. & Coy, D. H. Structure\u2013activity studies on the N-terminal region of glucagon. J. Med. Chem. 27, 310\u2013315 (1984).","journal-title":"J. Med. Chem."},{"key":"2182_CR31","doi-asserted-by":"publisher","first-page":"e2217604120","DOI":"10.1073\/pnas.2217604120","volume":"120","author":"BM Yussif","year":"2023","unstructured":"Yussif, B. M., Blasing, C. V. & Checco, J. W. Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide receptor family members. Proc. Natl Acad. Sci. USA 120, e2217604120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2182_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.molmet.2014.01.006","volume":"3","author":"J Chabenne","year":"2014","unstructured":"Chabenne, J. et al. A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia. Mol. Metab. 3, 293\u2013300 (2014).","journal-title":"Mol. Metab."},{"key":"2182_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fendo.2012.00141","volume":"3","author":"MJ Moon","year":"2012","unstructured":"Moon, M. J. et al. Structural and molecular conservation of glucagon-like peptide-1 and its receptor confers selective ligand-receptor interaction. Front. Endocrinol. 3, 141 (2012).","journal-title":"Front. Endocrinol."},{"key":"2182_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tibs.2008.05.001","volume":"33","author":"JM Neumann","year":"2008","unstructured":"Neumann, J. M. et al. Class-B GPCR activation: is ligand helix-capping the key?. Trends Biochem. Sci. 33, 314\u2013319 (2008).","journal-title":"Trends Biochem. Sci."},{"key":"2182_CR35","doi-asserted-by":"publisher","first-page":"12105","DOI":"10.1021\/jacs.3c01628","volume":"145","author":"R Gibadullin","year":"2023","unstructured":"Gibadullin, R., Cary, B. P. & Gellman, S. H. Differential responses of the GLP-1 and GLP-2 receptors to N-terminal modification of a dual agonist. J. Am. Chem. Soc. 145, 12105\u201312114 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1021\/cb200248h","volume":"6","author":"BF Binkowski","year":"2011","unstructured":"Binkowski, B. F. et al. A luminescent biosensor with increased dynamic range for intracellular cAMP. ACS Chem. Biol. 6, 1193\u20131197 (2011).","journal-title":"ACS Chem. Biol."},{"key":"2182_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1432-1033.1978.tb20953.x","volume":"91","author":"C Boesch","year":"1978","unstructured":"Boesch, C., Bundi, A., Oppliger, M. & W\u00fcthrich, K. 1H nuclear-magnetic-resonance studies of the molecular conformation of monomeric glucagon in aqueous solution. Eur. J. Biochem. 91, 209\u2013214 (1978).","journal-title":"Eur. J. Biochem."},{"key":"2182_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0167-4838(82)90468-X","volume":"709","author":"CD Tran","year":"1982","unstructured":"Tran, C. D., Beddard, G. S. & Osborne, A. D. Secondary structure and dynamics of glucagon in solution. Biochim. Biophys. Acta 709, 256\u2013264 (1982).","journal-title":"Biochim. Biophys. Acta"},{"key":"2182_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/0003-9861(69)90231-8","volume":"129","author":"PA Srere","year":"1969","unstructured":"Srere, P. A. & Brooks, G. C. The circular dichroism of glucagon solutions. Arch. Biochem. Biophys. 129, 708\u2013710 (1969).","journal-title":"Arch. Biochem. Biophys."},{"key":"2182_CR40","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.3390\/molecules27227805","volume":"27","author":"Z Bao","year":"2022","unstructured":"Bao, Z., Cheng, Y. C., Wei, J. J., Luo, M. Z. & Zhang, J. Y. Secondary structure characterization of glucagon products by circular dichroism and nuclear magnetic resonance spectroscopy. Molecules 27, 7805 (2022).","journal-title":"Molecules"},{"key":"2182_CR41","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41594-019-0238-6","volume":"26","author":"MD Gelenter","year":"2019","unstructured":"Gelenter, M. D. et al. The peptide hormone glucagon forms amyloid fibrils with two coexisting \u03b2-strand conformations. Nat. Struct. Mol. Biol. 26, 592\u2013598 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2182_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jmb.2005.09.100","volume":"355","author":"JS Pedersen","year":"2006","unstructured":"Pedersen, J. S. et al. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol. 355, 501\u2013523 (2006).","journal-title":"J. Mol. Biol."},{"key":"2182_CR43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1023\/B:PHAM.0000033016.36825.2c","volume":"21","author":"S Onoue","year":"2004","unstructured":"Onoue, S. et al. Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils. Pharm. Res. 21, 1274\u20131283 (2004).","journal-title":"Pharm. Res."},{"key":"2182_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1432-1033.1969.tb00735.x","volume":"11","author":"GH Beaven","year":"1969","unstructured":"Beaven, G. H., Gratzer, W. B. & Davies, H. G. Formation and structure of gels and fibrils from glucagon. Eur. J. Biochem. 11, 37\u201342 (1969).","journal-title":"Eur. J. Biochem."},{"key":"2182_CR45","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1021\/bi00475a025","volume":"29","author":"S Russ Lehrman","year":"1990","unstructured":"Russ Lehrman, S., Tuls, J. L. & Lund, M. Peptide \u03b1-helicity in aqueous trifluoroethanol: correlations with predicted \u03b1-helicity and the secondary structure of the corresponding regions of bovine growth hormone. Biochemistry 29, 5590\u20135596 (1990).","journal-title":"Biochemistry"},{"key":"2182_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0006-3495(98)77529-0","volume":"75","author":"CN Pace","year":"1998","unstructured":"Pace, C. N. & Scholtz, J. M. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 75, 422\u2013427 (1998).","journal-title":"Biophys. J."},{"key":"2182_CR47","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1021\/jacs.7b07930","volume":"139","author":"BF Fisher","year":"2017","unstructured":"Fisher, B. F., Hong, S. H. & Gellman, S. H. Helix propensities of amino acid residues via thioester exchange. J. Am. Chem. Soc. 139, 13292\u201313295 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"2182_CR48","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1172\/JCI92913","volume":"127","author":"L Zhu","year":"2017","unstructured":"Zhu, L. et al. Hepatic \u03b2-arrestin 2 is essential for maintaining euglycemia. J. Clin. Invest. 127, 2941\u20132945 (2017).","journal-title":"J. Clin. Invest."},{"key":"2182_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/1087057104263212","volume":"9","author":"M Vrecl","year":"2004","unstructured":"Vrecl, M., Jorgensen, R., Poga\u010dnik, A. & Heding, A. Development of a BRET2 screening assay using \u03b2-arrestin 2 mutants. J. Biomol. Screen. 9, 322\u2013333 (2004).","journal-title":"J. Biomol. Screen."},{"key":"2182_CR50","first-page":"141","volume":"220","author":"JW Black","year":"1983","unstructured":"Black, J. W. & Leff, P. Operational models of pharmacological agonism. Proc. R. Soc. B Biol. Sci. 220, 141\u2013162 (1983).","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"2182_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/cn200111m","volume":"3","author":"T Kenakin","year":"2012","unstructured":"Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A. & Novick, S. A simple method for quantifying functional selectivity and agonist bias. ACS Chem. Neurosci. 3, 193\u2013203 (2012).","journal-title":"ACS Chem. Neurosci."},{"key":"2182_CR52","doi-asserted-by":"publisher","first-page":"114150","DOI":"10.1016\/j.bcp.2020.114150","volume":"180","author":"S Darbalaei","year":"2020","unstructured":"Darbalaei, S. et al. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors. Biochem. Pharmacol. 180, 114150 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"2182_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/acsptsci.0c00193","volume":"4","author":"WJC Van Der Velden","year":"2021","unstructured":"Van Der Velden, W. J. C. et al. GLP-1 Val8: a biased GLP-1R agonist with altered binding kinetics and impaired release of pancreatic hormones in rats. ACS Pharmacol. Transl. Sci. 4, 296\u2013313 (2021).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2182_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03941-2","volume":"9","author":"B Jones","year":"2018","unstructured":"Jones, B. et al. Targeting GLP-1 receptor trafficking to improve agonist efficacy. Nat. Commun. 9, 1602 (2018).","journal-title":"Nat. Commun."},{"key":"2182_CR55","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1073\/pnas.262789099","volume":"100","author":"S Ahn","year":"2003","unstructured":"Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E. & Lefkowitz, R. J. Desensitization, internalization and signaling functions of \u03b2-arrestins demonstrated by RNA interference. Proc. Natl Acad. Sci. USA 100, 1740\u20131744 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2182_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/molpharm.120.000192","volume":"99","author":"E Moo Von","year":"2021","unstructured":"Moo Von, E., van Senten, J. R., Br\u00e4uner-Osborne, H. & M\u00f8ller, T. C. Arrestin-dependent and -independent internalization of G protein-coupled receptors: methods, mechanisms and implications on cell signaling. Mol. Pharmacol. 99, 242\u2013255 (2021).","journal-title":"Mol. Pharmacol."},{"key":"2182_CR57","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.chemphys.2004.08.002","volume":"307","author":"T Yoda","year":"2004","unstructured":"Yoda, T., Sugita, Y. & Okamoto, Y. Secondary-structure preferences of force fields for proteins evaluated by generalized-ensemble simulations. Chem. Phys. 307, 269\u2013283 (2004).","journal-title":"Chem. Phys."},{"key":"2182_CR58","doi-asserted-by":"publisher","first-page":"L07","DOI":"10.1529\/biophysj.108.132696","volume":"95","author":"RB Best","year":"2008","unstructured":"Best, R. B., Buchete, N. V. & Hummer, G. Are current molecular dynamics force fields too helical?. Biophys. J. 95, L07\u2013L09 (2008).","journal-title":"Biophys. J."},{"key":"2182_CR59","doi-asserted-by":"publisher","first-page":"020603","DOI":"10.1103\/PhysRevLett.100.020603","volume":"100","author":"A Barducci","year":"2008","unstructured":"Barducci, A., Bussi, G. & Parrinello, M. Well-tempered metadynamics: a smoothly converging and tunable free-energy method. Phys. Rev. Lett. 100, 020603 (2008).","journal-title":"Phys. Rev. Lett."},{"key":"2182_CR60","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1021\/acs.jmedchem.0c02069","volume":"64","author":"B Yang","year":"2021","unstructured":"Yang, B. et al. Optimization of truncated glucagon peptides to achieve selective, high potency, full antagonists. J. Med. Chem. 64, 4697\u20134708 (2021).","journal-title":"J. Med. Chem."},{"key":"2182_CR61","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cbic.201500312","volume":"17","author":"HM Werner","year":"2016","unstructured":"Werner, H. M., Cabalteja, C. C. & Horne, W. S. Peptide backbone composition and protease susceptibility: impact of modification type, position and tandem substitution. Chem. Bio. Chem. 17, 712\u2013718 (2016).","journal-title":"Chem. Bio. Chem."},{"key":"2182_CR62","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1021\/acs.jmedchem.2c00094","volume":"65","author":"T Kremsmayr","year":"2022","unstructured":"Kremsmayr, T. et al. On the utility of chemical strategies to improve peptide gut stability. J. Med. Chem. 65, 6191\u20136206 (2022).","journal-title":"J. Med. Chem."},{"key":"2182_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1432-1033.1974.tb03671.x","volume":"47","author":"W Ebeling","year":"1974","unstructured":"Ebeling, W. et al. Proteinase K from Tritirachium album Limber. Eur. J. Biochem. 47, 91\u201397 (1974).","journal-title":"Eur. J. Biochem."},{"key":"2182_CR64","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/anie.200705315","volume":"47","author":"W Seth Horne","year":"2008","unstructured":"Seth Horne, W. et al. Sequence-based design of \u03b1\/\u03b2-peptide foldamers that mimic BH3 domains. Angew. Chem. Int. Ed. 47, 2853\u20132856 (2008).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2182_CR65","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1021\/acschembio.0c00313","volume":"15","author":"JW Checco","year":"2020","unstructured":"Checco, J. W., Eddinger, G. A., Rettko, N. J., Chartier, A. R. & Gellman, S. H. Tumor necrosis factor-\u03b1 trimer disassembly and inactivation via peptide-small molecule synergy. ACS Chem. Biol. 15, 2116\u20132124 (2020).","journal-title":"ACS Chem. Biol."},{"key":"2182_CR66","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer, R. M. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434\u20131441 (2001).","journal-title":"N. Engl. J. Med."},{"key":"2182_CR67","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.molcel.2022.07.003","volume":"82","author":"K Kobayashi","year":"2022","unstructured":"Kobayashi, K. et al. Endogenous ligand recognition and structural transition of a human PTH receptor. Mol. Cell 82, 3468\u20133483.e5 (2022).","journal-title":"Mol. Cell"},{"key":"2182_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34009-x","volume":"13","author":"X Zhai","year":"2022","unstructured":"Zhai, X. et al. Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation. Nat. Commun. 13, 6276 (2022).","journal-title":"Nat. Commun."},{"key":"2182_CR69","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41401-022-01032-z","volume":"44","author":"L Zhao","year":"2022","unstructured":"Zhao, L. et al. Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1. Acta Pharmacol. Sin. 44, 1227\u20131237 (2022).","journal-title":"Acta Pharmacol. Sin."},{"key":"2182_CR70","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1021\/bi00458a032","volume":"29","author":"M Chorev","year":"1990","unstructured":"Chorev, M. et al. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists. Biochemistry 29, 1580\u20131586 (1990).","journal-title":"Biochemistry"},{"key":"2182_CR71","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1021\/acschembio.2c00595","volume":"17","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Kinetic and thermodynamic insights into agonist interactions with the parathyroid hormone receptor-1 from a new NanoBRET assay. ACS Chem. Biol. 17, 3148\u20133158 (2022).","journal-title":"ACS Chem. Biol."},{"key":"2182_CR72","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1021\/acs.jmedchem.7b00768","volume":"61","author":"PY Yang","year":"2018","unstructured":"Yang, P. Y. et al. Stapled, long-acting glucagon-like peptide 2 analog with efficacy in dextran sodium sulfate induced mouse colitis models. J. Med. Chem. 61, 3218\u20133223 (2018).","journal-title":"J. Med. Chem."},{"key":"2182_CR73","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1021\/jm100602m","volume":"53","author":"EN Murage","year":"2010","unstructured":"Murage, E. N., Gao, G., Bisello, A. & Ahn, J. M. Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges. J. Med. Chem. 53, 6412\u20136420 (2010).","journal-title":"J. Med. Chem."},{"key":"2182_CR74","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/ml400257h","volume":"4","author":"F Giordanetto","year":"2013","unstructured":"Giordanetto, F. et al. Stapled vasoactive intestinal peptide (VIP) derivatives improve VPAC 2 agonism and glucose-dependent insulin secretion. ACS Med. Chem. Lett. 4, 1163\u20131168 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"2182_CR75","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1021\/jm701522b","volume":"51","author":"LP Miranda","year":"2008","unstructured":"Miranda, L. P. et al. Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity. J. Med. Chem. 51, 2758\u20132765 (2008).","journal-title":"J. Med. Chem."},{"key":"2182_CR76","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tet.2018.11.060","volume":"75","author":"Y Tian","year":"2019","unstructured":"Tian, Y. et al. Design of stapled oxyntomodulin analogs containing functionalized biphenyl cross-linkers. Tetrahedron 75, 286\u2013295 (2019).","journal-title":"Tetrahedron"},{"key":"2182_CR77","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1021\/acschembio.2c00175","volume":"17","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Design of potent and proteolytically stable biaryl-stapled GLP-1R\/ GIPR peptide dual agonists. ACS Chem. Biol. 17, 1249\u20131258 (2022).","journal-title":"ACS Chem. Biol."},{"key":"2182_CR78","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","volume":"17","author":"EJ Whalen","year":"2011","unstructured":"Whalen, E. J., Rajagopal, S. & Lefkowitz, R. J. Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists. Trends Mol. Med. 17, 126\u2013139 (2011).","journal-title":"Trends Mol. Med."},{"key":"2182_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","volume":"12","author":"T Kenakin","year":"2012","unstructured":"Kenakin, T. & Christopoulos, A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat. Rev. Drug Discov. 12, 205\u2013216 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2182_CR80","doi-asserted-by":"publisher","first-page":"eaav0320","DOI":"10.1126\/scisignal.aav0320","volume":"14","author":"T Che","year":"2021","unstructured":"Che, T., Agnihotri, H. D., Shukla, A. K. & Roth, B. L. Biased ligands at opioid receptors: current status and future directions. Sci. Signal. 14, eaav0320 (2021).","journal-title":"Sci. Signal."},{"key":"2182_CR81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fphar.2019.00407","volume":"10","author":"KL Mores","year":"2019","unstructured":"Mores, K. L., Cummins, B. R., Cassell, R. J. & Van Rijn, R. M. A review of the therapeutic potential of recently developed G protein-biased kappa agonists. Front. Pharmacol. 10, 407 (2019).","journal-title":"Front. Pharmacol."},{"key":"2182_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.coph.2016.07.004","volume":"30","author":"CS Tautermann","year":"2016","unstructured":"Tautermann, C. S. Impact, determination and prediction of drug-receptor residence times for GPCRs. Curr. Opin. Pharmacol. 30, 22\u201326 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"key":"2182_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/acsptsci.0c00012","volume":"3","author":"WJC Van Der Velden","year":"2020","unstructured":"Van Der Velden, W. J. C., Heitman, L. H. & Rosenkilde, M. M. Perspective: implications of ligand-receptor binding kinetics for therapeutic targeting of G protein-coupled receptors. ACS Pharmacol. Transl. Sci. 3, 179\u2013189 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2182_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27760-0","volume":"13","author":"G Deganutti","year":"2022","unstructured":"Deganutti, G. et al. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation. Nat. Commun. 13, 92 (2022).","journal-title":"Nat. Commun."},{"key":"2182_CR85","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.1073\/pnas.1815294115","volume":"115","author":"S Liu","year":"2018","unstructured":"Liu, S., Cheloha, R. W., Watanabe, T., Gardella, T. J. & Gellman, S. H. Receptor selectivity from minimal backbone modification of a polypeptide agonist. Proc. Natl Acad. Sci. USA 115, 12383\u201312388 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2182_CR86","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & Mackerell, A. D. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 (2013).","journal-title":"J. Comput. Chem."},{"key":"2182_CR87","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","volume":"12","author":"S Doerr","year":"2016","unstructured":"Doerr, S., Harvey, M. J., No\u00e9, F. & De Fabritiis, G. HTMD: High-Throughput Molecular Dynamics for molecular discovery. J. Chem. Theory Comput. 12, 1845\u20131852 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"2182_CR88","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665\u2013W667 (2004).","journal-title":"Nucleic Acids Res."},{"key":"2182_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson, M. H. M., S\u00d8ndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525\u2013537 (2011).","journal-title":"J. Chem. Theory Comput."},{"key":"2182_CR90","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","volume":"22","author":"MA Lomize","year":"2006","unstructured":"Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. OPM: Orientations of Proteins in Membranes database. Bioinformatics 22, 623\u2013625 (2006).","journal-title":"Bioinformatics"},{"key":"2182_CR91","doi-asserted-by":"publisher","first-page":"e201302014","DOI":"10.5936\/csbj.201302014","volume":"5","author":"B Sommer","year":"2013","unstructured":"Sommer, B. Membrane packing problems: a short review on computational membrane modeling methods and tools. Comput. Struct. Biotechnol. J. 5, e201302014 (2013).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2182_CR92","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"2182_CR93","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1021\/ct9000685","volume":"5","author":"MJ Harvey","year":"2009","unstructured":"Harvey, M. J., Giupponi, G. & De Fabritiis, G. ACEMD: accelerating biomolecular dynamics in the microsecond time scale. J. Chem. Theory Comput. 5, 1632\u20131639 (2009).","journal-title":"J. Chem. Theory Comput."},{"key":"2182_CR94","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cplett.2003.12.039","volume":"384","author":"J \u00c5qvist","year":"2004","unstructured":"\u00c5qvist, J., Wennerstr\u00f6m, P., Nervall, M., Bjelic, S. & Brandsdal, B. O. Molecular dynamics simulations of water and biomolecules with a Monte Carlo constant pressure algorithm. Chem. Phys. Lett. 384, 288\u2013294 (2004).","journal-title":"Chem. Phys. Lett."},{"key":"2182_CR95","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/bip.360320508","volume":"32","author":"RJ Loncharich","year":"1992","unstructured":"Loncharich, R. J., Brooks, B. R. & Pastor, R. W. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N\u2032-methylamide. Biopolymers 32, 523\u2013535 (1992).","journal-title":"Biopolymers"},{"key":"2182_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler, V., Van Gunsteren, W. F. & H\u00fcnenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501\u2013508 (2001).","journal-title":"J. Comput. Chem."},{"key":"2182_CR97","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"2182_CR98","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1021\/ct900202f","volume":"5","author":"F Pietrucci","year":"2009","unstructured":"Pietrucci, F. & Laio, A. A collective variable for the efficient exploration of protein beta-sheet structures: application to SH3 and GB1. J. Chem. Theory Comput. 5, 2197\u20132201 (2009).","journal-title":"J. Chem. Theory Comput."},{"key":"2182_CR99","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cpc.2013.09.018","volume":"185","author":"GA Tribello","year":"2014","unstructured":"Tribello, G. A., Bonomi, M., Branduardi, D., Camilloni, C. & Bussi, G. PLUMED 2: new feathers for an old bird. Comput. Phys. Commun. 185, 604\u2013613 (2014).","journal-title":"Comput. Phys. Commun."},{"key":"2182_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual Molecular Dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"2182_CR101","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577\u20132637 (1983).","journal-title":"Biopolymers"},{"key":"2182_CR102","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller, B. R. et al. MMPBSA.py: an efficient program for end-state free energy calculations. J. Chem. Theory Comput. 8, 3314\u20133321 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"2182_CR103","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/cmdc.201100046","volume":"6","author":"A Cristiani","year":"2011","unstructured":"Cristiani, A. et al. The role of the N-terminal domain in the regulation of the \u2018constitutively active\u2019 conformation of protein kinase CK2\u03b1: insight from a molecular dynamics investigation. ChemMedChem 6, 1207\u20131216 (2011).","journal-title":"ChemMedChem"},{"key":"2182_CR104","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2182_CR105","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1073\/pnas.1221585110","volume":"110","author":"D Wootten","year":"2013","unstructured":"Wootten, D., Simms, J., Miller, L. J., Christopoulos, A. & Sexton, P. M. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl Acad. Sci. USA 110, 5211\u20135216 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2182_CR106","doi-asserted-by":"publisher","unstructured":"Deganutti, G. MD trajectories for \u2018potent and biased agonists of Class B1 GPCRs from a heterochiral design strategy\u2019\u2014Nature Chemistry. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19096161 (2026).","DOI":"10.5281\/zenodo.19096161"}],"container-title":["Nature Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02182-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:02:59Z","timestamp":1787914979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02182-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2182"],"URL":"https:\/\/doi.org\/10.1038\/s41557-026-02182-x","relation":{},"ISSN":["1755-4330","1755-4349"],"issn-type":[{"value":"1755-4330","type":"print"},{"value":"1755-4349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. This study was conducted in the absence of any academic or commercial collaborations with industry that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}